FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387427354> ?p ?o ?g. }

• W4387427354 endingPage "115648" @default.
• W4387427354 startingPage "115648" @default.
• W4387427354 abstract "Vimentin, an intermediate filament protein, crucially contributes to the pathogenesis of inflammatory bowel disease (IBD) by interacting with genetic risk factors, facilitating pathogen infection, and modulating both innate and adaptive immune responses. This study aimed to demonstrate preclinical proof-of-concept for targeting vimentin therapeutically in IBD across diverse etiologies.The small molecule compound ALD-R491 was assessed for vimentin binding using microscale thermophoresis, off-target effects via Eurofins screening, and therapeutic effects in mice with dextran sulfate sodium (DSS)-induced acute colitis and in IL-10 KO with spontaneous colitis. Parameters measured included body weight, survival, disease activity, colon length, and histology. The study analyzed intestinal proinflammatory cytokines, Th17/Treg cells, and epithelial barrier molecules, along with gut microbiota profiling.ALD-R491 specifically bound vimentin with a dissociation constant (KD) of 328 ± 12.66 nM and no off-target effects. In the DSS model, orally administered ALD-R491 exhibited dose-dependent therapeutic effects, superior to 5-ASA and Tofacitinib. In the IL-10 KO model, ALD-R491 significantly delayed colitis onset and progression, with near-zero disease activity index scores over a 15-week treatment. ALD-R491 consistently showed in both models a reduced proinflammatory cytokine expression, including TNF-α, IL-1β, IL-6, IL-17, IL-22, a rebalanced Th17/Treg axis by reducing RORγt while enhancing FoxP3 expression, and an improved epithelial barrier integrity by increasing intestinal expressions of Mucin-2, ZO-1 and Claudin5. The intestinal dysbiosis was restored with enriched presence of probiotics.Targeting vimentin exhibits significant therapeutic effects on various facets of IBD pathogenesis, representing a compelling approach for the development of highly effective treatments in IBD." @default.
• W4387427354 created "2023-10-08" @default.
• W4387427354 creator A5007297993 @default.
• W4387427354 creator A5014777980 @default.
• W4387427354 creator A5027702659 @default.
• W4387427354 creator A5030429211 @default.
• W4387427354 creator A5044328074 @default.
• W4387427354 creator A5045632834 @default.
• W4387427354 creator A5051773578 @default.
• W4387427354 creator A5052055984 @default.
• W4387427354 creator A5053207023 @default.
• W4387427354 creator A5065894155 @default.
• W4387427354 creator A5067141570 @default.
• W4387427354 date "2023-12-01" @default.
• W4387427354 modified "2023-10-11" @default.
• W4387427354 title "Therapeutic targeting of vimentin by ALD-R491 impacts multiple pathogenic processes to attenuate acute and chronic colitis in mice" @default.
• W4387427354 cites W1697354033 @default.
• W4387427354 cites W1967470547 @default.
• W4387427354 cites W1988866780 @default.
• W4387427354 cites W2033787709 @default.
• W4387427354 cites W2047971336 @default.
• W4387427354 cites W2064979804 @default.
• W4387427354 cites W2084672467 @default.
• W4387427354 cites W2097712502 @default.
• W4387427354 cites W2132784721 @default.
• W4387427354 cites W2143625465 @default.
• W4387427354 cites W2157162711 @default.
• W4387427354 cites W2163220944 @default.
• W4387427354 cites W2211069246 @default.
• W4387427354 cites W2337992351 @default.
• W4387427354 cites W2472899497 @default.
• W4387427354 cites W2749425110 @default.
• W4387427354 cites W2755548020 @default.
• W4387427354 cites W2770452796 @default.
• W4387427354 cites W2785836872 @default.
• W4387427354 cites W2886029455 @default.
• W4387427354 cites W2889835308 @default.
• W4387427354 cites W2900902086 @default.
• W4387427354 cites W2912291998 @default.
• W4387427354 cites W2927969134 @default.
• W4387427354 cites W2937189739 @default.
• W4387427354 cites W2954280934 @default.
• W4387427354 cites W2961464090 @default.
• W4387427354 cites W2969576341 @default.
• W4387427354 cites W3006764495 @default.
• W4387427354 cites W3020896942 @default.
• W4387427354 cites W3087071826 @default.
• W4387427354 cites W3124510804 @default.
• W4387427354 cites W3199851259 @default.
• W4387427354 cites W3207393109 @default.
• W4387427354 cites W4200510809 @default.
• W4387427354 cites W4200606012 @default.
• W4387427354 cites W4211147581 @default.
• W4387427354 cites W4220737061 @default.
• W4387427354 cites W4220947501 @default.
• W4387427354 cites W4225246105 @default.
• W4387427354 cites W4226032931 @default.
• W4387427354 cites W4285387403 @default.
• W4387427354 cites W4286488505 @default.
• W4387427354 cites W4288069747 @default.
• W4387427354 cites W4304196263 @default.
• W4387427354 cites W4309725971 @default.
• W4387427354 cites W4318478506 @default.
• W4387427354 cites W4368377522 @default.
• W4387427354 cites W4376132448 @default.
• W4387427354 doi "https://doi.org/10.1016/j.biopha.2023.115648" @default.
• W4387427354 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37812892" @default.
• W4387427354 hasPublicationYear "2023" @default.
• W4387427354 type Work @default.
• W4387427354 citedByCount "0" @default.
• W4387427354 crossrefType "journal-article" @default.
• W4387427354 hasAuthorship W4387427354A5007297993 @default.
• W4387427354 hasAuthorship W4387427354A5014777980 @default.
• W4387427354 hasAuthorship W4387427354A5027702659 @default.
• W4387427354 hasAuthorship W4387427354A5030429211 @default.
• W4387427354 hasAuthorship W4387427354A5044328074 @default.
• W4387427354 hasAuthorship W4387427354A5045632834 @default.
• W4387427354 hasAuthorship W4387427354A5051773578 @default.
• W4387427354 hasAuthorship W4387427354A5052055984 @default.
• W4387427354 hasAuthorship W4387427354A5053207023 @default.
• W4387427354 hasAuthorship W4387427354A5065894155 @default.
• W4387427354 hasAuthorship W4387427354A5067141570 @default.
• W4387427354 hasBestOaLocation W43874273541 @default.
• W4387427354 hasConcept C126322002 @default.
• W4387427354 hasConcept C147447768 @default.
• W4387427354 hasConcept C164027704 @default.
• W4387427354 hasConcept C203014093 @default.
• W4387427354 hasConcept C204232928 @default.
• W4387427354 hasConcept C2775862500 @default.
• W4387427354 hasConcept C2776914184 @default.
• W4387427354 hasConcept C2777165150 @default.
• W4387427354 hasConcept C2778260677 @default.
• W4387427354 hasConcept C2779134260 @default.
• W4387427354 hasConcept C502942594 @default.
• W4387427354 hasConcept C539455810 @default.
• W4387427354 hasConcept C71924100 @default.
• W4387427354 hasConcept C8891405 @default.
• W4387427354 hasConceptScore W4387427354C126322002 @default.

• next